NCT02152423View on ClinicalTrials.gov

Enoxamed Study in the Treatment of Acute Coronary Syndromes

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

June 30, 2014

Conditions
Acute Coronary Syndrome
Interventions
DRUG

LOVENOX

LMWH

DRUG

ENOXAMED

LMWH

Trial Locations (1)

5050

Emergency Department of University Hospital of Monastir, Monastir

All Listed Sponsors
collaborator

University Hospital Fattouma Bourguiba

OTHER

lead

University of Monastir

OTHER

NCT02152423 - Enoxamed Study in the Treatment of Acute Coronary Syndromes | Biotech Hunter | Biotech Hunter